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numbers of infl ammatory macrophages, 
and modulation of this established inju-
rious cell population may well be of 
benefi t. Our recent work used a model 
of conditional macrophage ablation in 
which the administration of minute 
doses of diphtheria toxin to mice trans-
genic for the human diphtheria toxin 
receptor under the CD11b promoter 
effectively ablates circulating mono-
cytes and renal macrophages. Ablation 
of monocytes/macrophages between 
days 15 and 20 of experimental crescen-
tic glomerulonephritis improved renal 
function and reduced the level of tubu-
lar-cell apoptosis and fi brosis.8 Th us, the 
targeted induction of apoptosis of infi l-
trating macrophages may be benefi cial 
in renal infl ammation.
An alternative means to reduce inter-
stitial macrophage numbers is to inhibit 
macrophage proliferation, as tubular 
cells are a rich source of the mitogen 
macrophage colony-stimulating factor, 
which supports macrophage prolifera-
tion.9 Also, as an alternative to attempt-
ing to reduce macrophage infi ltration, 
the administration of genetically modi-
fi ed macrophages has been attempted, 
with the macrophage being used as a 
‘Trojan horse’ to deliver anti-infl amma-
tory mediators such as interleukin-10 
or interleukin-1 receptor antagonist to 
the kidney.10 Benefi cial outcomes have 
been obtained in both glomerulone-
phritis and obstructive nephropathy.1,10 
Indeed, interleukin-10 released by the 
interleukin-10-overexpressing mac-
rophages localizing to the kidney may 
exert favorable eff ects on bystander host 
macrophages and facilitate their ‘repro-
gramming’ such that they adopt a less 
injurious phenotype.
We are slowly gaining a deeper under-
standing of the factors that govern 
monocyte recruitment and subsequent 
infiltration into the inflamed renal 
parenchyma, and the work of Lange-
Sperandio and colleagues3 adds to that 
knowledge. Although key questions 
have yet to be addressed, it is envisaged 
that manipulation of macrophage infi l-
tration, death, emigration, and pheno-
type may provide novel future strategies 
to limit infl ammatory injury and pro-
mote tissue repair.
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Role of the aldosterone-sensitive 
distal nephron in the sodium 
retention associated with liver 
cirrhosis
CA Ecelbarger1,2
The renal mechanisms underlying sodium retention during liver 
cirrhosis have been difficult to elucidate. Kim and associates describe 
a biphasic pattern of regulation of the renal epithelial sodium 
channel in the common bile duct ligation model, shedding some 
light on this issue.
Kidney International (2006) 69, 10–12. doi:10.1038/sj.ki.5000095
There has been some controversy as 
to the role of regulation of the renal 
sodium transporters and channels in the 
development of edema in animal mod-
els of cirrhosis. In a paper presented in 
this issue, Kim et al1demonstrate the 
complex and perhaps ‘biphasic’ nature 
of this regulation with regard to the 
epithelial sodium channel (ENaC) of 
the distal tubule in the model of com-
mon bile duct ligation (CBDL)-induced 
cirrhosis. Recognition of this apparent 
biphasic renal response to cirrhosis, 
with progression from the early to the 
late phase of decompensation,may help 
to clarify apparent discrepancies in a 
variety of earlier studies.
Sodium retention and liver cirrhosis
Liver cirrhosis is associated with a com-
pensatory stage in which there is evident 
peripheral vasodilation and increased 
cardiac output. In this early stage, there 
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is no evidence of ascites or fl uid reten-
tion. This is followed by a period of 
progressive decompensation character-
ized by increasingly severe edema and 
ascites. Inappropriate isotonic sodium 
retention is thought to occur in the early 
phase of decompensation, which is fol-
lowed by a later phase in which water is 
retained at a greater rate than sodium, 
resulting in hyponatremia.2,3 Th e trigger 
for the initiation of sodium retention 
by the kidney is not known, although 
evidence exists that sodium retention 
begins 1–2 weeks before the ascites 
becomes detectable.2 Also, it is appar-
ently associated with increased tubular 
sodium reabsorption, as the glomerular 
fi ltration rate (GFR) does not appear to 
be markedly aff ected. Th e thick ascend-
ing limb (TAL) and more distal sites —
that is, the aldosterone-sensitive distal 
nephron (ASDN) — have been impli-
cated.2–7 However, the relative impor-
tance of the TAL versus the post-macula 
densa ASDN has not been clarifi ed.
Th ere are two major rat models of liver 
cirrhosis. In the fi rst, rats are treated with 
carbon tetrachloride (CCl4) by inhalation 
in combination with phenobarbitone sup-
plied in the drinking water,3,4,6,8 which 
results in liver toxicity. In the second, rats 
have their common bile duct ligated, and 
the increased circulating levels of bile 
acids (cholestasis) result in hepatoxicity 
and eventually cirrhosis.1,7,9,10 Diff er-
ences in the severity, reproducibility, and 
rapidity of the manifestation of ascites in 
the two models probably play a role in 
some discrepancies.
Jonassen et al demonstrated increased 
natriuretic response to furosemide3 and 
increased volume of the epithelium of 
the TAL5 in cirrhotic rats, suggesting 
increased TAL sodium reabsorption 
at this site. However, an increase in the 
abundance of the bumetanide-sensitive 
Na-K-2Cl cotransporter has not been 
consistently demonstrated.8,10,11
The role of the distal tubule
In addition to increased activity of 
the TAL, there is strong evidence of 
increased post-macula densa sodium 
reabsorption in liver cirrhosis. The 
ASDN has been implicated by studies 
that show a reduction in sodium reten-
tion in cirrhotic patients treated with the 
mineralocorticoid receptor antagonist 
spironolactone.12 Th ere are two main 
aldosterone-regulated transporters or 
channels of sodium in the distal tubule, 
that is, in the distal convoluted tubule 
(DCT) cells: the thiazide-sensitive Na-
Cl cotransporter, and — in the later part 
of the DCT, the connecting tubule, and 
the collecting duct — the amiloride-
sensitive ENaC. Whereas some reports4,7 
have described an increase in renal Na-
Cl cotransporter abundance in cirrhotic 
rats, others have shown a decrease.8 It 
is likely that some of these discrepan-
cies were due to the ‘phasic’ nature of 
sodium retention in these models.
What is meant by the biphasic nature 
of sodium retention in cirrhosis? As 
they report in this issue, Kim and asso-
ciates1 determined that, somewhere 
between 6 and 8 weeks aft er the CBDL, 
rats converted from a mainly sodium-
retaining period of cirrhosis (phase 1) 
into one in which they were mainly 
in balance, perhaps eff ectively ‘escap-
ing’ from volume expansion due to 
activation of countering mechanisms 
(phase 2) (Figure 1). For their study, 
rats were killed 6 or 8 weeks aft er the 
CBDL. Th e authors determined that at 6 
weeks the rats were in the early phase of 
decompensation. Th ese rats had detect-
able ascites, and an increased urinary 
sodium-to-potassium ratio, which indi-
cates high aldosterone activity; however, 
their plasma aldosterone levels were not 
elevated. Th ese rats did have decreased 
renal abundance of 11-β-hydroxysteroid 
dehydrogenase (11-β-HSD-2), which 
might have allowed non-metabolized 
corticosterone in these cells to bind to 
the mineralocorticoid receptor. Further-
more, although there was no evidence 
of increased protein abundance for the 
ENaC subunits, there was an increase 
in subcellular traffi  cking into the apical 
plasma membrane, as determined by 
immunoperoxidase labeling.
At 8 weeks the rats were determined to 
be in a later stage of decompensation and 
had nearly twice the volume of ascitic 
fl uid that the 6-week rats had. However, 
fractional excretion of sodium and the 
sodium-to-potassium ratio in the urine 
were not diff erent, which indicates that 
these rats were no longer in a relative 
sodium-retaining phase but were now 
in an equilibrium period. Plasma aldos-
terone levels were suppressed. Th ese rats 
actually had decreased renal abundance 
of ENaC subunits, and no evidence of 
altered subcellular distribution of the 
proteins, despite the fact that 11-β-HSD-
Figure 1| Biphasic response of sodium retention in liver cirrhosis. Phase 1 (depicted on 
the left) is primarily a phase of sodium retention due to decreased activity of 11-β-HSD-2, 
with subsequent sodium retention by the distal tubule, as well as increased TAL sodium 
retention. This leads to volume expansion. In phase 2, (depicted on the right) net sodium 
retention is absent if rats are able to effectively 'escape' by means of a reduction in ENaC- and 
NaCl cotransporter (NCC)-mediated sodium retention. In some instances, rats are unable to 
effectively escape and remain in a relatively sodium-retentive phase. The determinants and 
modulators of escape are not well understood.
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2 was still decreased. Increased relative 
apical distribution clearly might play a 
role in enhanced sodium retention in the 
early phase; this might be accomplished 
by decreased 11-β-HSD-2, but we are 
still left  wondering why this decrease in 
11-β-HSD-2 was not able to elicit traf-
fi cking in the later stage. Th e authors 
suggest that the decrease in aldosterone 
(about a 50% reduction) may have been 
important. Th is may be true, depending 
on how important, in a physiological 
sense, a 50% reduction in the abundance 
of 11-β-HSD-2 protein is with regard to 
its activity and, thus, how much cortico-
sterone escaped conversion in these rats, 
as corticosterone circulates at nearly ten 
times the level of aldosterone.
These results do not agree entirely 
with those of Fernandez-Llama et al4 
in the CCl4 model of cirrhosis. They 
reported massive ascites, which suggests 
a later phase of decompensation; how-
ever, aldosterone levels were increased, 
as was the renal abundance of the
 α-subunit of ENaC, which has been 
shown to be increased by aldosterone. 
We can speculate that the degree of cir-
rhosis induced in this model was more 
severe and that the rats were therefore 
unable to adapt and achieve sodium 
balance via aldosterone-escape-like 
mechanisms and, thus, remained in 
a high-aldosterone state. Fernandez-
Llama and colleagues4 did not measure 
11-β-HSD-2 abundance or activity.
Kim and associates1 also examined 
the regulation of ENaC in the CCl4 
model. Th ey found high variability in 
the response of the rats to treatment, 
and thus they split them into groups 
based on their urinary sodium-to-
potassium ratio. Th ose that had lower 
sodium-to-potassium ratios (increased 
aldosterone activity) had decreased 
11-β-HSD-2, increased traffi  cking of 
ENaC, and increased appearance of 
the 70-kilodalton band of γ-ENaC (an 
aldosterone-stimulated band).
A major role for 11-β-HSD-2 activity?
In 1999, Ackerman and colleagues9 
described an increase in 11-β-HSD-2 
activity in the microdissected cortical 
collecting ducts and urine collected 
from rats with CBDL-induced cirrho-
sis. In vitro, they demonstrated that the 
bile acid chenodeoxycholic acid dose-
dependently inhibited 11-β-HSD-2 
activity in the cortical collecting ducts 
with a Ki of 19.9 µmol/l. In addition, 
they showed that, 4 weeks after bile 
duct ligation, 11-β-HSD-2 activity was 
decreased in cortical collecting ducts, 
an observation preceded by a reduced 
mRNA content at weeks 2 and 3. Th ey 
hypothesized that down-regulation of 
II-β-HSD-2 could play a role in dis-
tal tubular sodium retention. Th us, it 
seems plausible that this may be the 
initial stimulator of sodium retention 
in the ASDN during liver cirrhosis. 
What role does altered hemodynamics 
play? Kim and associates1 showed mod-
est decreases in creatinine clearance in 
CBDL rats at both 6 and 8 weeks; this 
may have decreased the sodium load 
to the macula densa and triggered 
increased activity of the renin–angi-
otensin–aldosterone system. Another 
factor that may reduce the sodium 
load to the macula densa is increased 
sodium-reabsorptive activity of the 
TAL.3–5 However, the initial trigger for 
increased TAL sodium reabsorption in 
liver cirrhosis is less clear, as the TAL is 
not part of the ASDN and probably does 
not express 11-β-HSD-2.
Overview
The sodium-retaining phase of liver 
cirrhosis may be initially the result of 
downregulation of 11-β-HSD-2 activity, 
which may allow for increased signaling 
through the mineralocorticoid recep-
tor independent of the circulating level 
of aldosterone. In addition, depend-
ing on the severity of the cirrhosis and 
probably on hemodynamic factors, this 
may be accompanied by activation of the 
renin–angiotensin–aldosterone system, 
leading to increased circulating levels of 
aldosterone. Kim and associates1 have 
defi ned a biphasicity of the regulation 
of sodium reabsorption in their CBDL 
model. Early on, they observed activa-
tion of ENaC, probably the result of 
increased 11-β-HSD-2 activity and 
ENaC traffi  cking into the apical mem-
brane. Later on, they observed a period 
of sodium balance with decreased aldos-
terone levels. Th is phase may represent 
active and successful escape from the 
sodium retention by means of down-
regulation of the activity of the ASDN. 
It is not entirely clear whether these 
phases are always temporally related 
in this manner, or whether additional 
unknown factors determine how and 
whether the kidney is able to escape.
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